Google Search
Search
Already a Member ?
Active Pharma Ingredients Metformin And Ciprofloxacin Production Business | |
| Metformin (also known as Glucophage) is an oral diabetes medication that helps the body use insulin more effectively and lower blood sugar levels. Metformin is a diabetes treatment that can be taken alone or with other diabetes drugs. It has no side effects like hypoglycemia or weight gain, which are common with other diabetic treatments. Metformin does not cure diabetes, but it can help you manage your blood sugar and lower your risk of problems if you take it as prescribed by your doctor. Metformin is the first-line treatment for type 2 diabetes, especially in overweight individuals, and is sold under the brand names Glucophage and others. Polycystic ovarian syndrome (PCOS) is also treated with it (PCOS). It's taken orally and hasn't been linked to weight gain. It's sometimes used off-label to aid people who take antipsychotics or phenelzine avoid gaining weight. Metformin is a biguanide, which is a type of antihyperglycemic medication. It works by lowering glucose production in the liver, improving insulin sensitivity in body tissues, and increasing GDF15 secretion to reduce hunger and calorie intake. Metformin is a drug that is used to treat high blood sugar levels caused by type 2 diabetes, sometimes known as sugar diabetes. In this type of diabetes, the pancreas' insulin is unable to carry sugar into the body's cells, where it can operate normally. Metformin can help lower blood sugar and restore the way you use food to make energy when it's too high, either alone or in combination with a type of oral antidiabetic medicine called a sulfonylurea, or insulin. Metformin is a drug that aids in the regulation of blood sugar levels in persons with type 2 diabetes. It's also used as a second-line treatment for infertility caused by polycystic ovarian syndrome. Infections of the urinary tract (not recommended as a first-line antibiotic) Ciprofloxacin is the active ingredient in Ciprofloxacin, an antibiotic. It prevents germs from copying their DNA, which is how it works. It's primarily used to treat infections of the urinary tract, respiratory tract, prostate gland, skin and soft tissue infections, and anthrax because of its broad spectrum of activity against Gram-positive and Gram-negative bacteria, as well as its ability to penetrate bacterial biofilms and stationary phase cells in both aerobic and anaerobic environments. In 1983, Bayer A.G. developed ciprofloxacin, which was approved by the US Food and Drug Administration (FDA) in 1987. The FDA has licenced ciprofloxacin for 12 human and veterinary uses, however it is routinely used for unapproved reasons (off-label). Antibiotics, herbal and natural supplements, and thyroid therapies are among the medications that interact with ciprofloxacin. • Acute uncomplicated cystitis in women • Chronic bacterial prostatitis in men (not recommended as a first-line antibiotic choice) • Respiratory tract infections are less common (not recommended as a first-line antibiotic choice) • Acute sinusitis (not recommended as a first-line antibiotic choice) • Infections of the skin and the tissues that support it • Infections of the bones and joints • Infectious diarrhoea • Salmonella typhi-caused typhoid fever (enteric fever) Metformin hydrochloride API producers are strengthening their manufacturing capacities to lessen their reliance on China as anti-China sentiment grows in India. Due to interruptions in supplies from China as a result of the COVID-19 pandemic, manufacturers have been ramping up domestic production of active medicinal components (APIs). Despite the fact that India is known as the world's pharmacy because to its vast production capabilities in generic pharmaceuticals and vaccines, China is proving to be a tough rival, accounting for half of worldwide API supply. Indian drug companies are seeking to domestic producers to minimise their reliance on China in the metformin hydrochloride API business, as ties between the two countries have improved since a deadly border clash in June 2020. The Indian ciprofloxacin market is likely to grow rapidly over the forecast period. The ciprofloxacin market in India is being driven by the increased prevalence of renal disorders and eye infections, among other things. Ciprofloxacin is a second-generation fluoroquinolone that is used to treat a range of ear infections, including otitis externa, which is expected to drive market growth through FY2026. In addition, the market is expected to grow in the next years as the demand for broad-spectrum antibiotics that can treat a wide range of gram-positive and gram-negative bacteria grows. Key Players: • Aarti Drugs Ltd. • Abhilasha Pharma Pvt. Ltd. • Auro Laboratories Ltd. • Corvine Chemicals & Pharmaceuticals Ltd. • Godavari Drugs Ltd. • Harman Finochem Ltd. | |
| Plant capacity: Metformin: 2,000 Kgs. Per Day | Ciprofloxacin: 1,000 Kgs. Per Day | Plant & machinery: 104 Lakhs |
| Working capital: N/A | T.C.I: Cost of Project: 584 Lakhs |
| Return: 31.00% | Break even: 58.00% |
Email Us |
 Add to Inquiry Basket | |
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.
Information- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
About NIIR PROJECT CONSULTANCY SERVICES | Hide  |
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.
Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.
NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.
Copyright © 2003-2021 NPCS.
